From ADEA <[email protected]>
Subject ADEA Advocate - February 9, 2021
Date February 9, 2021 3:52 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
View this email in your browser [ [link removed] ] .

American Dental Education Association

Volume 1, No. 97, February 9, 2021

ADEA Advocacy in Action
This appears weekly in the ADEA Advocate to summarize and provide direct links to recent advocacy actions taken by ADEA. Please let us know what you think and how we might improve its usefulness.
 
COVID Related Capital Needs
Jan 28 – Joint letter [ [link removed] ] regarding HEERF grants
Jan 24 – ADEA memo [ [link removed] ] regarding vaccines at the state level
 
Other COVID Issues
Jan 4 – ADEA memo [ [link removed] ] regarding vaccine allocation
Jan 4 – ADEA memo [ [link removed] ] regarding Provider Relief Fund
Jan 4 – Joint letter [ [link removed] ] regarding COVID-19 policy changes
 
Additional Resources
ADEA webinar [ [link removed] ] on State Advocacy
NHSC Service Loan Repayment Program user guide [ [link removed] ] and application portal [ [link removed] ]
For a full list of ADEA Letters and Policy Memos, click here [ [link removed] ] .

Johnson & Johnson Applies for EUA for COVID-19 Vaccine
 
Johnson & Johnson submitted its request for Emergency Use Authorization (EUA) [ [link removed] ] from the Food and Drug Administration (FDA) for its coronavirus vaccine. If approved [ [link removed] ] , the vaccine would be the third approved vaccine in the United States and it requires only one dose. The vaccine has a 72% efficacy rate in the United States and 57% percent efficacy rate in South Africa, which has the most contagious variant of the coronavirus. Though not as efficacious as the Pfizer and Moderna vaccines, the Johnson & Johnson vaccine is 85% effective in preventing severe disease, providing the strongest protection against severe disease.
 
The Johnson & Johnson vaccine costs less than the Pfizer and Moderna vaccines and can be stored at refrigerator temperatures. Because of its easy of storage, costs and efficacy—especially against the South African variant—this vaccine offers the hope of getting more people vaccinated quickly. The Johnson & Johnson vaccine is considered a strong candidate for an FDA EUA approval.

Now Available: Update to Summary of Legislation and Regulations Addressing Prescription Drug and Opioid Abuse
 
Annually, ADEA staff conduct a review and compile a summary of all recently passed legislation and regulations intended to address prescription drug and opioid abuse. An update to the summary is now available online. The summary [ [link removed] ] provides a brief overview of state policies enacted in 2020 to help dental professionals stay up to date on recent changes to laws and regulations that affect opioid-prescribing practices while receiving the latest information on other changes to opioid policy that are relevant to academic dentistry.
 
To view recently proposed and enacted legislative and regulatory changes that would impact opioid policy, please visit the ADEA U.S. Interactive Legislative and Regulatory Tracking Map [ [link removed] ] and select “Opioids” from the menu. Information on the ADEA interactive map is updated daily.

DOJ Withdraws Lawsuit Accusing Yale of Discrimination
 
The Department of Justice (DOJ) submitted a Notice of Dismissal [ [link removed] ] in its case against Yale University. The lawsuit, originally brought under the Trump administration, accused Yale of having stricter admission standards for white and Asian-American candidates, which would have been in violation of Title VI of the 1964 Civil Rights Act. The case stemmed from a 2016 complaint by the Asian-American Coalition for Education against Yale, Brown University and Dartmouth College.
 
The DOJ noted that it would continue monitoring Yale to ensure compliance with Title VI of the 1964 Civil Rights Act.
 
The withdrawal from the case signals a possible change in the Department’s approach to affirmative action cases under the Biden administration.

New York Senate Passes Bill to Require Cultural Awareness and Competency Training
 
On Feb. 2, the New York Senate [ [link removed] ] passed a bill that would require cultural awareness and competence continuing education training for medical professionals. The legislation applies to numerous health care professionals, including dentists, and would require such cultural awareness and competence course work or training to be two hours and encompass minority health care issues, such as ethnic, religious, linguistic, sexual orientation and gender identity health care issues and their impact on minority health care.
 
The bill will now be sent to the state Assembly for consideration.

Mississippi House Passes Bill to Increase Licensure Portability
 
On Feb. 3, the Mississippi House of Representatives voted to pass legislation that would increase licensure portability in the state. Similar to recently created laws in other states, the bill would require licensing boards to grant a license to numerous licensed professionals, including dentists and dental hygienists, who establish residency in the state and who have held licenses that are in good standing in another jurisdiction for at least one year. In addition to establishing residency, an applicant for licensure by reciprocity cannot have faced or be facing specified discipline or complaints. Current state law already extends this courtesy to members of the military, military spouses and their dependents. The bill will now go to the state Senate for consideration.
 
In recent years, similar bills have passed in Arizona [ [link removed] ] , Iowa [ [link removed] ] and Missouri [ [link removed] ] , but unlike Arizona and Iowa, Missouri does not require an applicant to be a resident of the state.

ADEA State Calendar [ [link removed] ]

ADEA Washington Calendar [ [link removed] ]

ADEA U.S. Interactive Legislative and Regulatory Tracking Map [ [link removed] ]

Key Federal Issues [ [link removed] ]

Key State Issues [ [link removed] ]

The ADEA Advocate [ [link removed] ] is published weekly. Its purpose is to keep ADEA members abreast of federal and state issues and events of interest to the academic dentistry and the dental and research communities.
 
©2021
American Dental Education Association
655 K Street, NW, Suite 800
Washington, DC 20001
202-289-7201, adea.org [ [link removed] ]

twitter
[link removed]

Unsubscribe
[link removed]

Subscribe
[link removed][0]&p_colname=p_last_nm&p_varname=p_val_arr[1]&p_colname=p_alias&p_varname=p_val_arr[2]&p_colname=p_login_id&p_varname=p_val_arr[3]&p_colname=p_passwd&p_context=NEWSLETTER&p_success_url=censsaindprofile.section_update%3Fp_profile_ty%3DINDIVIDUAL_PROFILE%26p_skip_confirm_fl%3DY%26p_section_nm%3DNewsletters%26p_format%3D110%26p_msg_txt%3D%26p_cust_id%3D%26p_referrer%3Dadeacenssalandingpage.display_page%3Fp_context%3DNEWSLETTER

B. Timothy Leeth, CPA
ADEA Chief Advocacy Officer
 
Bridgette DeHart, J.D.
ADEA Director of Federal Relations and Advocacy
 
Phillip Mauller, M.P.S.
ADEA Director of State Relations and Advocacy
 
Brian Robinson
ADEA Program Manager for Advocacy and Government Relations
 
[email protected] [ [link removed] ]

Powered by Higher Logic [link removed]
Screenshot of the email generated on import

Message Analysis